Vadim Kolodny

Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances to quickly build up to detectable levels, meaning shorter screening times. The separation of the cell population into droplets containing single cells with no crosstalk means you get highly accurate, single-cell resolution results of the heterogeneous activity or potency of the cells rather than an averaged readout that hides critical information. Xdrop and Xdrop Sort are ideal for engineered cell therapy research, protein engineering and other synthetic biology workflows, and other cell interaction- or cell secretion-based workflow.

Fjord is one of a few private equity firms globally which focus exclusively on investing in the resource efficiency and clean energy. The firm invests in the lower mid-market companies (not assets/projects) pursuing buyout and growth opportunities, with the objective of creating value through an active industrial ownership model.

Space Venture Fund is a unique venture fund specifically investing in revolution that we encounter in space and space related industries. This includes different segments of value chain such as satellite earth observation, geospatial, Internet of Things, Big Data and AI.

BARD Worldwide is a multi-asset investment fund established in 2007. The firms investment approach encompasses: 1. Private Portfolio - Private Equity (growth equity and buyouts), Private Debt, Real Estate and Venture Capital investments across variety of industries and stages. 2. Public Portfolio - equity, fixed income, commodities, derivatives, hedge funds, semi-liquid real estate and other. Employing highly selective deal-generation process, substantial part of the Bard’s Private investment portfolio is formed via systematic and consistent commitments into the strictly selected high-quality private equity funds and deals globally each year on the primary and secondary markets. Industry expertise includes Biotech, Technology, Clean Energy, Ag-tech, Space, Software & IT, Banking and other. Bard uses balanced allocation investment approach, actively managing each asset class within the overall portfolio, achieving diversified risk-adjusted returns.

Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances to quickly build up to detectable levels, meaning shorter screening times. The separation of the cell population into droplets containing single cells with no crosstalk means you get highly accurate, single-cell resolution results of the heterogeneous activity or potency of the cells rather than an averaged readout that hides critical information. Xdrop and Xdrop Sort are ideal for engineered cell therapy research, protein engineering and other synthetic biology workflows, and other cell interaction- or cell secretion-based workflow.

Fjord is one of a few private equity firms globally which focus exclusively on investing in the resource efficiency and clean energy. The firm invests in the lower mid-market companies (not assets/projects) pursuing buyout and growth opportunities, with the objective of creating value through an active industrial ownership model.

Foresight Capital Partners is medium-sized Russian private equity firm established in 2007. We invest at growth capital stage in private companies through straight and syndicated deals. Our long-term objective is to support best business practices in Russia by helping truly exceptional leadership teams to excel in their industries leveraging on our international experience and partnership networks. We aim to secure our ability to exert influence (not necessarily through majority ownership) in the investee companies. Our plausible investment rage starts from $1m and above per each deal.